研究将遗传与GLP-1减肥药的有效性联系起来. Study links genetics to GLP-1 weight loss drug effectiveness.

一项新的研究表明,遗传学可能会影响GLP-1减肥药物如Ozempic和Wegovy的效果. A new study suggests genetics may influence how well GLP-1 weight-loss drugs like Ozempic and Wegovy work. 研究人员发现一种特定的基因变异与体重减轻有微增加相关, 但影响很小, 可能会被恶心等副作用所抵消. Researchers found a specific gene variant linked to slightly greater weight loss, but the effect is modest and may be offset by increased side effects like nausea. 专家说, 这项研究结果最终可以帮助医生个性化治疗, 但在广泛使用之前还需要更多的研究. Experts say findings could eventually help doctors personalize treatment, though more research is needed before widespread use.